Current position:Home >Product >
5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime(1044506-82-2)
- Name: 5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
- Synonyms:5-PyriMidinecarboxaldehyde, 4-aMino-6-[[1-[(3-fluorophenyl)Methyl]-1H-indazol-5-yl]aMino]-, O-(2-Methoxyethyl)oxiMe
- Molecular Formula:C22H22FN7O2
- Molecular Weight:435.461
- CAS Registry Number:1044506-82-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.1044506-82-2 5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
Assay:99% Application:api
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.1044506-82-2 5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 515134-70-0/[1,1'-Biphenyl]-3,4'-dicarboxamide, N3-cyclopropyl-N4'-(cyclopropylmethyl)-6-methyl-
- 1093222-29-7/[1,1'-Biphenyl]-4-carboxamide, N-(cyclopropylmethyl)-2'-methyl-5'-[[3-(1-piperidinyl)benzoyl]amino]-
- 926922-29-4/AP 24149
- 926922-16-9/Benzamide, 3-[(1E)-2-[6-(cyclopropylamino)-9H-purin-9-yl]ethenyl]-4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-
- 592543-24-3/L-Alanine, N-[2-methoxy-5-[[[(1E)-2-(2,4,6-trimethoxyphenyl)ethenyl]sulfonyl]methyl]phenyl]-
- 883065-90-5/4-(2,3-Dihydro-1,4-benzodioxin-6-yl)-2,4-dihydro-5-[(5-nitro-2-thiazolyl)thio]-3H-1,2,4-triazol-3-one
- 870962-74-6/2-Butenamide, 4-(dimethylamino)-N-[4-[[3,6-dioxo-4-(phenylmethoxy)-1,4-cyclohexadien-1-yl]amino]-7-ethoxy-6-quinazolinyl]-, (2E)-
- 1032314-85-4/Benzamide, N-[4-methyl-3-[[4-(6-methyl-3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]-
- 1196450-91-5/1H-Pyrrole-3-carboxamide, N-[2-(diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-1-methyl-2-oxo-3H-indol-3-ylidene)methyl]-2,4-dimethyl-
- 862823-06-1/Furo[2,3-d]pyrimidine-2,4-diamine, 5-[(1E)-2-(1-naphthalenyl)-1-propen-1-yl]-
- 947403-26-1/3-Quinolinecarbonitrile, 4-[(2-amino-6-benzothiazolyl)amino]-6-methyl-7-[2-(1-piperidinyl)ethoxy]-
- 1140412-34-5/2-Butenamide, N-[2,5-bis(trifluoromethyl)phenyl]-2-cyano-3-hydroxy-, (2Z)-
- 179343-59-0/Pyrido[2,3-d]pyrimidine-2,7-diamine, 6-(2,6-dimethylphenyl)-
- 673451-39-3/2-Pyrimidinamine, N-cyclohexyl-4-[3-phenyl-5-(1-piperidinylmethyl)-4-isoxazolyl]-
- 1056016-06-8/2-[[9-(1-Methylethyl)-6-[[3-(2-pyridinyl)phenyl]amino]-9H-purin-2-yl]amino]-1-butanoldihydrochloride
- 1196450-97-1/1H-Indazole-5-carbonitrile, 3,6-diamino-4-phenyl-
- 207400-81-5/1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-[1-(phenylmethyl)-1H-tetrazol-5-yl][1,1'-biphenyl]-4-yl]methyl]-
- 207400-83-7/Glycyllosartan
- 211934-97-3/EMD-66397
- 1044506-82-2/5-Pyrimidinecarboxaldehyde, 4-amino-6-[[1-[(3-fluorophenyl)methyl]-1H-indazol-5-yl]amino]-, O-(2-methoxyethyl)oxime
- 254750-02-2/(S)-3-((S)-2-(2-(2-tert-butylphenylamino)-2-oxoacetamido)propanamido)-4-oxo-5-(2,3,5,6-tetrafluorophenoxy)pentanoic acid
- 223568-55-6/EP-1013
- 586379-66-0/PH 797804
- 444606-18-2/SB-681323
- 1006036-87-8/4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid
- 1006036-88-9/4-[1-[[[2,5-Dimethyl-4-[[4-(trifluoromethyl)phenyl]methyl]-3-thienyl]carbonyl]amino]cyclopropyl]benzoic acid sodium salt
- 706802-34-8/Benzenesulfonamide, N-[[[2-[4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino]carbonyl]-4-methyl-
- 1021950-26-4/Tyrosine kinase inhibitor
- 936890-98-1/OSI-027
- 802539-81-7/PHA-848125